Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 23:2018:8340563.
doi: 10.1155/2018/8340563. eCollection 2018.

Elucidation of the Intestinal Absorption Mechanism of Loganin in the Human Intestinal Caco-2 Cell Model

Affiliations

Elucidation of the Intestinal Absorption Mechanism of Loganin in the Human Intestinal Caco-2 Cell Model

Renjie Xu et al. Evid Based Complement Alternat Med. .

Abstract

Loganin, iridoid glycosides, is the main bioactive ingredients in the plant Strychnos nux-vomica L. and demonstrates various pharmacological effects, though poor oral bioavailability in rats. In this study, the intestinal absorption mechanism of loganin was investigated using the human intestinal Caco-2 cell monolayer model in both the apical-to-basolateral (A-B) and the basolateral-to-apical (B-A) direction; additionally, transport characteristics were systematically investigated at different concentrations, pHs, temperatures, and potential transporters. The absorption permeability (PappAB) of loganin, which ranged from 12.17 to 14.78 × 10-6cm/s, was high at four tested concentrations (5, 20, 40, and 80μM), while the major permeation mechanism of loganin was found to be passive diffusion with active efflux mediated by multidrug resistance-associated protein (MRP) and breast cancer resistance protein (BCRP). In addition, it was found that loganin was not the substrate of efflux transporter P-glycoprotein (P-gp) since the selective inhibitor (verapamil) of the efflux transporter exhibited little effects on the transport of loganin in the human intestinal Caco-2 cells. Meanwhile, transport from the apical to the basolateral side increased 2.09-fold after addition of a MRP inhibitor and 2.32-fold after addition of a BCRP inhibitor. In summary, our results clearly demonstrate, for the first time, a good permeability of loganin in the human intestinal Caco-2 cell model and elucidate, in detail, the intestinal absorption mechanism and the effects of transporters on iridoid glycosides compounds.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The chemical structure of loganin.
Figure 2
Figure 2
Typical chromatogram of a separation of loganin (1) and IS (2) in fresh blank HBSS (A) and a sample (B) 5 minutes after transport experiments by LC/MS/MS (45.97ng/mL for loganin and 0.08ng/mL for IS).
Figure 3
Figure 3
Time Course of loganin transport across human intestinal Caco-2 cell monolayers at different concentrations (n = 3).
Figure 4
Figure 4
Apparent permeability coefficient (PappAB, 60 min) of loganin (20 μM) in the AP-to-BL direction in human intestinal Caco-2 cells previously treated at different PH values and temperatures (n = 3, p < 0.05).

Similar articles

Cited by

References

    1. Tsai W.-H., Wu C.-H., Cheng C.-H., Chien C.-T. Ba-Wei-Di-Huang-Wan through its active ingredient loganin counteracts substance P-enhanced NF-κB/ICAM-1 signaling in rats with bladder hyperactivity. Neurourology and Urodynamics. 2016;35(7):771–779. doi: 10.1002/nau.22816. - DOI - PubMed
    1. Chao G., Tian X., Zhang W., Ou X., Cong F., Song T. Blocking Smad2 signalling with loganin attenuates SW10 cell cycle arrest induced by TNF-α. PLoS ONE. 2017;12(5) - PMC - PubMed
    1. Ma W., Wang K. J., Cheng C.-S., et al. Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy. Journal of Ethnopharmacology. 2014;153(3):840–845. doi: 10.1016/j.jep.2014.03.051. - DOI - PubMed
    1. Kim M.-J., Bae G.-S., Jo I.-J. Loganin protects against pancreatitis by inhibiting NF-κB activation. European Journal of Pharmacology. 2015;765:541–550. doi: 10.1016/j.ejphar.2015.09.019. - DOI - PubMed
    1. Li Y., Li Z., Shi L., et al. Loganin inhibits the inflammatory response in mouse 3T3L1 adipocytes and mouse model. International Immunopharmacology. 2016;36:173–179. doi: 10.1016/j.intimp.2016.04.026. - DOI - PubMed

LinkOut - more resources